生物活性 | |||
---|---|---|---|
描述 | JI-101 is an orally available multi-kinase inhibitor of VEGFR2, PDGFRβ and EphB4 with potent anti-cancer activity[1]. | ||
作用机制 | JI-101 inhibits VEGFR‐2, PDGFR‐β, and EphB4 by directly binding to their sites, thereby mediating antiangiogenic and antineoplastic activities mediated by these kinases. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.14mL 0.43mL 0.21mL |
10.72mL 2.14mL 1.07mL |
21.44mL 4.29mL 2.14mL |
参考文献 |
---|